Next Article in Journal
Sex Differences in Vestibular Schwannoma
Next Article in Special Issue
Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does Not
Previous Article in Journal
Recruitment and Retention Strategies Used in Dietary Randomized Controlled Interventions with Cancer Survivors: A Systematic Review
Previous Article in Special Issue
Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying Covariates
 
 
Article

Article Versions Notes

Cancers 2023, 15(17), 4368; https://doi.org/10.3390/cancers15174368
Action Date Notes Link
article xml file uploaded 1 September 2023 08:35 CEST Original file -
article xml uploaded. 1 September 2023 08:35 CEST Update https://www.mdpi.com/2072-6694/15/17/4368/xml
article pdf uploaded. 1 September 2023 08:35 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4368/pdf
article supplementary file uploaded. 1 September 2023 08:35 CEST - https://www.mdpi.com/2072-6694/15/17/4368#supplementary
article html file updated 1 September 2023 08:36 CEST Original file https://www.mdpi.com/2072-6694/15/17/4368/html
Back to TopTop